What Trends Are Transforming the Benralizumab Drug Industry?
The biopharmaceutical sector is evolving at a breakneck pace, and patient-centric innovations are rewriting the rules of chronic disease management. The Benralizumab Drug industry was valued at USD 1,689 Million in 2024 and is projected to grow to USD 2,976 Million by 2030, with a compound annual growth rate (CAGR) of 10.06% from 2025 to 2030. A major driver of this shift is the growing...
0 Commentarii 0 Distribuiri 67 Views 0 previzualizare
Sponsor